Skip to main content

Salsolinol — An endogenous neurotoxin in the biology of alcoholism

  • Conference paper
New and Upcoming Markers of Alcohol Consumption
  • 58 Accesses

Abstract

Similarities between alcoholism and morphinism concerning the development of an addiction and symptoms of withdrawal led to the hypothesis that opiate-active compounds might be formed endogenously during the establishment of alcohol addiction. This theory was supported by the proof of the in vivo formation of simple tetrahydroisoquinoline alkaloids like salsolinol via Pictet-Spengler reaction from dopamine and the ethanol oxidation product acetaldehyde in the human body. Salsolinol was demonstrated to have a variety of neuropharmacological and cytotoxic effects and shows an affinity to the dopamine receptors. Definite evidence for a salsolinol formation in elevated concentrations after alcohol abuse is still lacking. In systematic regional studies using human brains we found significant amounts of salsolinol in the dopaminergic system, which is responsible for addiction processes. The possibility that biosynthesis of salsolinol occurs through a stereospecific enzymatic reaction was considered and both salsolinol enantiomers were found in human brain samples with no correlations between levels of salsolinol and dopamine. These findings do not support the hypothesis that only an enantio-selective synthesis of (R)-salsolinol by a putative salsolinol synthase is responsible for the in vivo formation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Brossi A. (1982) Mammalian TIQ’s: products of condensation with aldehydes or pyruvic acids? Prog. Clin. Biol. Res., 90, 125–133.

    PubMed  CAS  Google Scholar 

  • Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M. and Kopin I.J. (1983) A primate model of parkinsonism:selective destruction of dopaminergic neurons in the pars compacta of substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci.USA, 80, 4546–4550.

    Article  PubMed  CAS  Google Scholar 

  • Chiba K., Trevor A.J. and Castagnoli N. (1984) Metabolism of the neurotoxic amine, MPTP, by brain monoamine oxidase. Biochem. Biphys. Res. Commun., 120, 574–578.

    Article  CAS  Google Scholar 

  • Chiueh C.C., Miyake H. and Peng M.-T. (1993) Role of dopamine autooxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism. Adv. Neurol., 60, 251–258.

    PubMed  CAS  Google Scholar 

  • Clow A., Topham A., Saunders J.B., Murray R. and Sandler M. (1985) The role of salsolinol in alcohol intake and withdrawal. Prog. Clin. Biol. Res., 183, 101–113.

    PubMed  CAS  Google Scholar 

  • Cohen G. and Collins M. (1970) Alkaloids from catecholamines in adrenal tissue: Possible role in alcoholism. Science, 167, 1749–1751.

    Article  PubMed  CAS  Google Scholar 

  • Collins A.C., Cashaw J.L. and Davis V.E. (1973) Dopamine-derived tetrahydroisoquinoline alkaloids — inhibitors of neuroamine metabolism. Biochem. Pharmacol., 22, 2337–2348.

    Article  PubMed  CAS  Google Scholar 

  • Collins M.A., Nijm W.P., Borge G.F., Teas G. and Goldfarb C. (1979) Dopamine-related tetrahydroi-soquinolines: significant urinary excretion by alcoholics after alcohol consumption. Science, 206, 1184–1186.

    Article  PubMed  CAS  Google Scholar 

  • Dave J.R., Lee E.E., Karanian J.W. and Eskay R.L. (1986) Ethanol exposure decreases pituitary corti-cotrophin-releasing factor binding, adenylate cyclase activity, proopiomelanocortin biosynthesis and plasma β-endorphin. Endocrinology, 118, 280–286.

    Article  PubMed  CAS  Google Scholar 

  • Davis V.E. and Walsh M.J. (1970) Alcohol, amines, and alkaloids: A possible biochemical basis for alcohol addiction. Science, 167, 1005–1007.

    Article  PubMed  CAS  Google Scholar 

  • Deng Y., Maruyama W., Dostert P., Takahashi T., Kawai M. and Naoi M. (1995) Determination of the (R)- and (S)-enantiomers of salsolinol and N-methylsalsolinol by use of a chiral high-performance liquid chromatographic column. J. Chromatogr. B, 670, 47–54.

    Article  CAS  Google Scholar 

  • Deng Y., Maruyama W., Kawai M., Dostert P., Yamamura H., Takahashi T. and Naoi M. (1997) Assay for the (R)- and (S)-enantiomers of salsolinols in biological samples and foods with ion-pair high-performance liquid chromatography using beta-cyclodextrin as a chiral mobile phase additive. J. Chromatogr. B, 689, 313–320.

    Article  CAS  Google Scholar 

  • Deng Y., Maruyama W., Yamamura H., Kawai M., Dostert P. and Naoi M. (1996) Mechanism of enantioseparation of salsolinols, endogenous neurotoxins in human brain, with ion-pair chromatography using beta-cyclodextrin as a mobile phase additive. Anal. Chem., 68, 2826–2831.

    Article  PubMed  CAS  Google Scholar 

  • Dostert P., Strolin Benedetti M. and Dedieu M. (1987) Ratio of enantiomers of salsolinol in human urine. Pharmacol. Toxicol., 60 [Suppl. 1], 13.

    Google Scholar 

  • Dostert P., Strolin Benedetti M. and Dordain G. (1988) Dopamine-derived alkaloids in alcoholism and in Parkinson’s and Huntington’s diseases. J. Neural Transm., 74, 61–74.

    Article  PubMed  CAS  Google Scholar 

  • Dostert P., Strolin Benedetti M., Dordain G. and Vernay D. (1991) Urinary elimination of salsolinol enantiomers in alcoholics. J. Neural Transm., 85, 51–59.

    Article  CAS  Google Scholar 

  • Duncan M.W. and Smythe G.A. (1982) Salsolinol and dopamine in alcoholic beverages [letter]. Lancet, 1, 904–905.

    Article  PubMed  CAS  Google Scholar 

  • Faraj B.A., Camp V.M., Davis D.C., Lenton J.D. and Kutner M. (1989) Elevation of plasma salsolinol sulfate in chronic alcoholics as compared to nonalcoholics. Alcohol Clin. Exp. Res., 13, 155–163.

    Article  PubMed  CAS  Google Scholar 

  • Feest U., Kemper A., Nickel B., Rabe H. and Koalick F. (1992) Comparison of salsolinol excretion in alcoholics and nonalcoholic controls. Alcohol, 9, 49–52.

    Article  PubMed  CAS  Google Scholar 

  • Genazzani A.R., Nappi G., Facchinetti G.L., Mazella G.L., Petraglia F. and Savoldi F. (1982) Central deficiency of beta-endorphine in alcohol addicts. Clin. Endocrinol. Metab., 55, 583–586.

    Article  CAS  Google Scholar 

  • Haber H. and Melzig M. (1992) [Tetrahydroisoquinolines — endogenous products from chronic alcohol abuse]. Pharmazie, 47, 3–7.

    PubMed  CAS  Google Scholar 

  • Haber H., Henklein P., Georgi M. and Melzig M.F. (1995a) Resolution of catecholic tetrahydroisoquinoline enantiomers and the determination of R- and S-salsolinol in biological samples by gas chromatography-mass spectrometry. J. Chromatogr. B, 672, 179–187.

    Article  CAS  Google Scholar 

  • Haber H., Putscher I., Georgi M. and Melzig M.F. (1995b) Influence of ethanol on the salsolinol excretion in healthy subjects. Alcohol, 12, 299–303.

    Article  PubMed  CAS  Google Scholar 

  • Haber H., Winkler A., Putscher I., Henklein P., Baeger I., Georgi M. and Melzig M.F. (1996) Plasma and urine salsolinol in humans: effect of acute ethanol intake on the enantiomeric composition of salsolinol. Alcohol Clin. Exp. Res., 20, 87–92.

    Article  PubMed  CAS  Google Scholar 

  • Heikkila R., Cohen G. and Dembiec D. (1971) Tetrahydroisoquinoline alkaloids: uptake by rat brain homogenates and inhibition of catecholamine uptake. Pharmacol. Exp. Ther., 179, 250–258.

    CAS  Google Scholar 

  • Kajita M., Niwa T., Maruyama W., Nakahara D., Takeda N., Yoshizumi H., Tatematsu A., Watanabe K., Naoi M. and Nagatsu T. (1994) Endogenous synthesis of N-methylnorsalsolinol in rat brain during in vivo microdialysis with epinine. J. Chromatogr. B, 654, 263–269.

    Article  CAS  Google Scholar 

  • Kikuchi K., Nagatsu Y., Makino Y., Mashino T., Ohta S. and Hirobe M. (1991) Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroi-soquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline. Drug Metab. Dispos., 19, 257–262.

    PubMed  CAS  Google Scholar 

  • Langsten J.W., Ballard P., Tetrud J.W. and Irwin I. (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science, 219, 979–980.

    Article  Google Scholar 

  • Lasala J.M. and Coscia C.J. (1979) Accumulation of a tetrahydroisoquinoline in phenylketonuria. Science, 203, 283–284.

    Article  PubMed  CAS  Google Scholar 

  • Maruyama W., Abr T., Toghi H., Dostert P. and Naoi M. (1996a) A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in parkinsonian CSF. Ann. Neurol., 40, 119–122.

    Article  PubMed  CAS  Google Scholar 

  • Maruyama W., Dostert P. and Naoi M. (1995a) Dopamine-derived l-methyl-6,7-dihydroxyisoquinoli-nes as hydroxyl radical promoters and scavengers in the rat brain: in vivo and in vitro studies. J. Neurochem., 64, 2635–2643.

    Article  PubMed  CAS  Google Scholar 

  • Maruyama W., Dostert P., Matsubara K. and Naoi, M. (1995b) N-methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity. Free Radic. Biol. Med., 19, 67–75.

    Article  PubMed  CAS  Google Scholar 

  • Maruyama W., Nakahara D., Ota M., Takahashi T., Takahashi A., Nagatsu T. and Naoi M. (1992) N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4- tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study. J. Neurochem., 59, 395–400.

    Article  PubMed  CAS  Google Scholar 

  • Maruyama W., Narabayashi H., Dostert P. and Naoi M. (1996b) Stereospecific occurrence of a parkin-sonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid. J. Neural Transm., 103, 1069–1076.

    Article  PubMed  CAS  Google Scholar 

  • Maruyama W., Sobue G., Matsubara K., Hashizume Y., Dostert P. and Naoi M. (1997) A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2, 3,4-tetrahydroisoquinoline, N-me-thyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain. Neurosci. Lett., 223, 61–64.

    Article  PubMed  CAS  Google Scholar 

  • McNaught K.S., Altomare C., Cellamare S., Carotti A., Thull U., Carrupt P.A., Testa B., Jenner P. and Marsden C.D. (1995a) Inhibition of alpha-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-1,2,3,6-tetrahydropyridine (MPTP). Neuroreport, 6, 1105–1108.

    Article  PubMed  CAS  Google Scholar 

  • McNaught K.S., Thull U., Carrupt P.A., Altomare C., Cellamare S., Carotti A., Testa B., Jenner P. and Marsden C.D. (1995b) Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP). Biochem. Pharmacol., 50, 1903–1911.

    Article  PubMed  CAS  Google Scholar 

  • Melzig M.F., Putscher I., Haber H., Rottmann M. and Zipper J. (1998) Toxicity and pharmacological effects of salsolinol in different cultivated cells. In: Moser A. (ed.), Pharmacology of endogenous neurotoxins — a handbook (pp. 253–266). Boston: Birkhaeuser.

    Chapter  Google Scholar 

  • Meyerson L.R., McMurtrey K.D. and Davis V.E. (1976) Neuroamine-derived alkaloids: Substrate-preferred inhibitors of rat brain monoamine oxidase in vitro. Biochem. Pharmacol., 25, 1013–1020.

    Article  PubMed  CAS  Google Scholar 

  • Minami M., Maruyama W., Dostert P., Nagatsu T. and Naoi M. (1993) Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1, 2,3,4-tetrahydroisoquinolines and their N-methylated derivatives. J. Neural Transm., 92, 125–135.

    Article  CAS  Google Scholar 

  • Minami M., Takahashi T., Maruyama W., Takahashi A., Dostert P., Nagatsu T. and Naoi M. (1992) Inhibition of tyrosine hydroxylase by R and S enantiomers of salsolinol, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline. J. Neurochem., 58, 2097–2101.

    Article  PubMed  CAS  Google Scholar 

  • Mizuno Y., Saitoh T. and Sone N. (1987a) Inhibition of mitochondrial NADH-ubiquinone oxidore-ductase activity by 1-methyl-4-phenyIpyridinium ion. Biochem. Biophys. Res. Commun., 143, 294–299.

    Article  PubMed  CAS  Google Scholar 

  • Mizuno Y., Suzuki K., Sone N. and Saitoh T. (1987b) Inhibition of ATP synthesis by 1-methyl-4-phenylpyridinium ion (MPP+) in isolated mitochondria from mouse brains. Neurosci. Lett., 81, 204–208.

    Article  PubMed  CAS  Google Scholar 

  • Müller T., Przuntek H., Kuhn W., Sällström Baum S. and Rommelspacher H. (1999) No increase of synthesis of (R)salsolinol in Parkinson’s disease. Mov. Disord., 14, 514–515.

    Article  PubMed  Google Scholar 

  • Musshoff F., Daldrup T., Bonte W., Leitner A. and Lesch O.M. (1996) Formaldehyde-derived tetrahy-droisoquinolines and tetrahydro-beta- carbolines in human urine. J. Chromatogr. B, 683, 163–176.

    Article  CAS  Google Scholar 

  • Musshoff F., Daldrup T., Bonte W., Leitner A. and Lesch, O.M. (1997) Salsolinol and norsalsolinol in human urine samples. Pharmacol. Biochem. Behav., 58, 545–550.

    Article  PubMed  CAS  Google Scholar 

  • Musshoff F., Schmidt P., Dettmeyer R., Priemer F., Jachau K. and Madea B. (2000) Determination of dopamine and dopamine-derived (R)-/(S)-salsolinol and norsalsolinol in various human brain areas using solid-phase extraction and gas chromatography / mass spectrometry. Forensic Sci. Int., 113, 356–366.

    Google Scholar 

  • Musshoff F., Schmidt P., Dettmeyer R., Priemer F., Wittig H. and Madea B. (1999) A systematic study of dopamine and dopamine-derived salsolinol and norsalsolinol levels in human brain areas. Forensic Sci. Int., 105, 1–11.

    Article  PubMed  CAS  Google Scholar 

  • Myers R.D. (1989) Isoquinolines, beta-carbolines and alcohol drinking: involvement of opioid and dopaminergic mechanisms. Experientia, 45, 436–443.

    Article  PubMed  CAS  Google Scholar 

  • Myers R.D. and Melchior C.L. (1977) Differential actions on voluntary alcohol intake of tetrahydroi-soquinolines or a beta-carboline infused chronically in the ventricle of the rat. Pharmacol. Biochem. Behav, 7, 381–392.

    Article  PubMed  CAS  Google Scholar 

  • Nagatsu, T. (1997) Isoquinoline neurotoxins in the brain and Parkinson’s disease. Neurosci. Res, 29, 99–111.

    Article  PubMed  CAS  Google Scholar 

  • Nagatsu T. and Yoshida M. (1988) An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci. Lett, 87, 178–182.

    Article  PubMed  CAS  Google Scholar 

  • Naoi M., Maruyama W. and Dostert P. (1995a) Dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroi-soquinolines; oxidation and neurotoxicity. Prog. Brain Res, 106, 227–239.

    Article  PubMed  CAS  Google Scholar 

  • Naoi M., Maruyama W., Dostert P. and Hashizume Y. (1996a) Animal model of parkinson’s disease induced by naturely-occuring 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline. Biogenic Amines, 12, 132–147.

    Google Scholar 

  • Naoi M., Maruyama W., Dostert P., Kohda K. and Kaiya T. (1996b) A novel enzyme enantio-selecti-vely synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol. Neurosci.Lett., 212, 183–186.

    Article  PubMed  CAS  Google Scholar 

  • Naoi M., Maruyama W., Matsubara K. and Hashizume Y. (1997) A neutral N-methyltransferase activity in the striatum determines the level of an endogenous MPP+-like neurotoxin, 1,2- dimethyl-6,7-dihydroxyisoquinolinium ion, in the substantia nigra of human brains. Neurosci.Lett, 235, 81–84.

    Article  PubMed  CAS  Google Scholar 

  • Naoi M., Maruyama W., Zhang J.H., Takahashi T., Deng Y. and Dostert P. (1995b) Enzymatic oxidation of the dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroiso-quinoline, into 1, 2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion. Life Sci, 57, 1061–1066.

    Article  PubMed  CAS  Google Scholar 

  • Origitano T.C. and Collins M.A. (1984) Gas chromatographic analysis of endogenous catecholamines, phenolic amines and derived isoquinolines using short glass capillary columns and electron-capture detection. J. Chromatogr, 311, 17–29.

    Article  PubMed  CAS  Google Scholar 

  • Pianezzola E., Bellotti V., Fontana E., Moro E., Gal J. and Desai D.M. (1989) Determination of the enantiomeric composition of salsolinol in biological samples by high-performance liquid chromatography with electrochemical detection. J. Chromatogr, 495, 205–214.

    Article  PubMed  CAS  Google Scholar 

  • Riggin R.M., McCarthy M.J. and Kissinger, P.T. (1976) Identification of salsolinol as a major dopamine metabolite in the banana. J. Agric. Food Chem., 24, 189–191.

    Article  PubMed  CAS  Google Scholar 

  • Robbins J.H. (1968) Alkaloid formation by condensation of biogenic amines with acetaldehyde. Clin. Res, 16, 350–350.

    Google Scholar 

  • Rommelspacher H. and Susilo R. (1985) Tetrahydroisoquinolines and beta-carbolines: putative natural substances in plants and mammals. Prog. Drug Res, 29, 415–459.

    Article  PubMed  CAS  Google Scholar 

  • Rommelspacher H., Sälistrom Baum S., Dufeu P. and Schmidt L.G. (1995) Determination of (R)- and (S)-salsolinol sulfate and dopamine sulfate levels in plasma of nonalcoholics and alcoholics. Alcohol, 12, 309–315.

    Article  PubMed  CAS  Google Scholar 

  • Sällström Baum S. and Rommelspacher H. (1994) Determination of total dopamine, R- and S-salsolinol in human plasma by cyclodextrin bonded-phase liquid chromatography with electrochemical detection. J. Chromatogr. B, 660, 235–241.

    Article  Google Scholar 

  • Sandler M., Carter S.B., Hunter K.R. and Stern G.M. (1973) Tetrahydroisoquinoline alkaloids: in vivo metabolites of L-dopa in man. Nature, 241, 439–443.

    Article  PubMed  CAS  Google Scholar 

  • Sasaoka T., Kaneda N., Niwa T., Hashizume Y. and Nagatsu T. (1988) Analysis of salsolinol in human brain using high-performance liquid chromatography with electrochemical detection. J. Chromatogr, 428, 152–155.

    Article  PubMed  CAS  Google Scholar 

  • Seizinger B.R., Höllt V. and Herz A. (1984) Effects of chronic ethanol treatment on the in vitro biosynthesis of pro-opiomelanocortin and its posttranslational processing to beta-endorphin in the intermediate lobe of the rat pituitary. J. Neurochem., 43, 607–613.

    Article  PubMed  CAS  Google Scholar 

  • Sjöquist B. and Magnuson E. (1980) Analysis of salsolinol and salsoline in biological samples using deuterium-labelled internal standards and gas chromatography — mass spectrometry. J. Chromatogr., 183, 17–24.

    Article  PubMed  Google Scholar 

  • Sjöquist B., Borg S. and Kvande H. (1981a) Catecholamine derived compounds in urine and cerebrospinal fluid from alcoholics during and after long-standing intoxication. Subst.Alcohol Actions Misuse., 2, 63–72.

    PubMed  Google Scholar 

  • Sjöquist B., Borg S. and Kvande H. (1981b) Salsolinol and methylated salsolinol in urine and cerebrospinal fluid from healthy volunteers. Subst. Alcohol Actions Misuse., 2, 73–77.

    PubMed  Google Scholar 

  • Sjöquist B., Eriksson A. and Winblad B. (1982) Salsolinol and catecholamines in human brain and their relation to alcoholism. Prog. Clin. Biol. Res., 90, 57–67.

    PubMed  Google Scholar 

  • Smythe G.A. and Duncan M.W. (1985) Precise GC/MS assays for salsolinol and tetrahydropapaveroline: the question of artifacts and dietary sources and the influence of alcohol. Prog. Clin. Biol. Res., 183, 77–84.

    PubMed  CAS  Google Scholar 

  • Strolin Benedetti M., Bellotti V., Pianezzola E., Moro E., Carminati P. and Dostert P. (1989a) Ratio of the R and S enantiomers of salsolinol in food and human urine. J. Neural Transm., 77, 47–53.

    Article  Google Scholar 

  • Strolin Benedetti M., Dostert P. and Carminati, P. (1989b) Influence of food intake on the enantiomeric composition of urinary salsolinol in man. J. Neural Transm., 78, 43–51.

    Article  Google Scholar 

  • Takahashi T., Deng Y., Maruyama W., Dostert P., Kawai M. and Naoi M. (1994) Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system. J. Neural Transm., 98, 107–118.

    Article  CAS  Google Scholar 

  • Weiner C. and Collins M. (1978) Tetrahydroisoquinolines derived from catecholamines or dopa: Effects on brain tyrosine hydroxylase activity. Biochem. Pharmacol., 27, 2699–2703.

    Article  PubMed  CAS  Google Scholar 

  • Winkler A., Roske I., Furkert J., Fickel J. and Melzig M.F. (1995) Effects of voluntary ethanol ingestion on the POMC gene expression in the rat pituitary and on the plasma β-endorphin content. Alcohol Alcoholism, 30, 231–238.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Steinkopff Verlag Darmstadt

About this paper

Cite this paper

Musshoff, F. (2001). Salsolinol — An endogenous neurotoxin in the biology of alcoholism. In: Wurst, F.M. (eds) New and Upcoming Markers of Alcohol Consumption. Steinkopff. https://doi.org/10.1007/978-3-642-96008-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-96008-6_8

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-96010-9

  • Online ISBN: 978-3-642-96008-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics